RAD51 and ovarian serous adenocarcinoma: Our previous research found that miR-506-3p overexpression played an essential role in regulating the sensitivity to cisplatin and Olaparib by inhibiting the CDK4/6-FOXM1 pathway and RAD51-HR axis in serous ovarian cancer cells 13, 14.